IMC opposes a January 15, 2021 proposal to redefine ‘gap’ medicines and change the timeline for compliance – which halves the transition period to six months.
PMPRB Guidelines Notice and Comment
resources
Discover. Learn.
Understand.
Informative content to keep you up to date on the most pressing issues facing our industry.
